Exercise program aims to ease joint pain in older breast cancer survivors
NCT ID NCT03955627
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tested whether a self-management program combining exercise classes and group discussions could relieve joint pain caused by aromatase inhibitors (AI) in older breast cancer survivors. Twelve women aged 60 and older who were starting AI medication took part. The program included 8 weeks of supervised Zoom sessions followed by 8 weeks of home-based exercise with coaching calls. Researchers measured pain levels and medication adherence over a year.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- exercise and education program
- What this could lead to
- If it works, this could offer a simple, drug-free way to manage joint pain and improve medication adherence in older breast cancer survivors.
- What could go wrong
- This is a very small pilot study with only 12 participants, so results may not apply to everyone. The program is delivered via Zoom, which may not suit all older adults.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
12 people
The number who actually took part.
- Started
-
Jun 2021
- Finished
-
Jul 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
60 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Female, aged ≥ 60 years at the start of study * Planning to initiate AIs * Diagnosed stages I-III Breast Cancer * R+ tumor (at least 5% of cells) * Completed surgery, radiation and/or chemotherapy * Independent ambulatory (verified by treating clinician/staff) * Physician approval to start an exercise program * Must report insufficient physical activity (\<150 min. of physical activity per week) * Able to complete surveys and forms/ understand English * Agree to random assignment to exercise or control group * Can commit to 8 weeks, bi-weekly classes offered by Zoom video * Must have internet access and/or data plan by which to participate in Zoom video sessions * Minimum cognitive impairment (verified by cognitive screening questions administered by phone or in-person interview) Exclusion Criteria: * Already taking Aromatase Inhibitors (AIs) (may participate if 24 weeks or less after initiating) * Presence of metastatic cancer or concurrent malignancy requiring treatment * Recent history (past 6 months) of stroke/ Myocardial Infarction (MI), atrial fibrillation or class 3, 4 heart failure * Recent joint surgery or conditions limiting PA
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a faster radiation course match the standard one after breast reconstruction?
- Can High-Risk breast cancer patients skip an extra radiation boost?
- Radioactive probe lights up CD73 on breast tumors in PET scans
- Can time with horses help cancer patients feel better?
- Can an oral drug replace injections for advanced breast cancer?
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?